Business Description
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Business History
Price Overview
Last updated: Jun 27, 2026 10:09am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -1.22
Total Equity: $1.73B
Shares: 45,896,000
Total Debt: $59.03M
Cash: $279.78M
EBITDA: $54.07M
Total Debt: $59.03M
Cash: $279.78M
Revenue: $593.82M
Shares: 45,896,000
Revenue: $593.82M
Revenue: $593.82M
Revenue: $593.82M
Total Equity: $1.73B
Tax Rate: 442.4%
Equity: $1.73B
Total Debt: $59.03M
Cash: $279.78M
Current Liabilities: $237.67M
Long-Term Debt: $51.24M
Total Debt: $59.03M
Total Equity: $1.73B
Shares: 45,896,000
Shares: 45,896,000
CapEx: -$33.86M
Shares: 45,896,000
Stock Price: $25.50
Net Income: -$55.76M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 23, 2026 6:40pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $513.7M | $555.5M | $665.1M | $573.4M | $593.8M |
| Cost of Revenue | $299.2M | $324.9M | $431.8M | $318.8M | $323.5M |
| Gross Profit | $214.5M | $230.6M | $233.3M | $254.6M | $270.3M |
| Operating Expenses | $210.9M | $254.6M | $315.5M | $284.6M | $281.5M |
| Operating Income | $3.6M | -$24.0M | -$82.2M | -$30.0M | -$11.3M |
| Net Income | $110.7M | -$429.0M | -$14.3M | -$164.9M | -$55.8M |
| EBITDA | $9.9M | $48.4M | $55.2M | $71.6M | $54.1M |
| EPS | $-0.39 | $-0.15 | $-0.22 | $-3.09 | $-1.22 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 23, 2026 6:40pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $227.4M | $658.3M | $678.9M | $310.9M | $279.8M |
| Total Current Assets | $777.4M | $2.5B | $1.4B | $832.8M | $708.3M |
| Total Assets | $1.8B | $3.7B | $2.9B | $2.1B | $2.1B |
| Current Liabilities | $345.1M | $230.5M | $210.9M | $204.8M | $237.7M |
| Long-Term Debt | $49.7M | $0 | $0 | $0 | $51.2M |
| Total Liabilities | $494.2M | $352.7M | $351.2M | $331.1M | $330.7M |
| Total Equity | $1.3B | $3.4B | $2.5B | $1.8B | $1.7B |
| Retained Earnings | -$470.1M | $1.7B | $1.6B | $1.5B | $1.4B |
Cash Flow (Annual)
Last updated: Jun 23, 2026 6:40pm (3d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $149.9M | -$466.0M | $5.8M | $49.7M | $72.2M |
| Capital Expenditure | -$52.8M | -$77.4M | -$39.4M | -$37.4M | -$33.9M |
| Free Cash Flow | $97.1M | -$543.5M | -$33.6M | $12.4M | $38.3M |
| Acquisitions (net) | -$95.5M | $2.8B | -$386.5M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | -$838.5M | -$661.7M | $0 |
| Net Change in Cash | -$17.2M | $756.0M | -$357.3M | -$363.1M | -$24.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 1:16am (8h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$629.5M $618.1M – $633.1M
|
$675.0M $662.8M – $678.8M
|
$683.5M $671.1M – $687.4M
|
$742.8M $729.4M – $747.0M
|
| EBITDA |
$110.3M $108.3M – $110.9M
|
$118.2M $116.1M – $118.9M
|
$119.7M $117.6M – $120.4M
|
$130.1M $127.8M – $130.8M
|
| Net Income |
$27.9M $27.5M – $28.4M
|
$38.9M $36.8M – $41.0M
|
$59.7M $58.3M – $60.1M
|
$80.8M $78.9M – $81.4M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 23, 2026 6:40pm (3d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +8.1% | +19.7% | -13.8% | +3.6% |
| Gross Profit Growth | +7.5% | +1.1% | +9.2% | +6.1% |
| Operating Income Growth | -768.0% | -242.2% | +63.5% | +62.4% |
| Net Income Growth | -487.3% | +96.7% | -1,056.6% | +66.2% |
| EBITDA Growth | +386.5% | +14.1% | +29.9% | -24.5% |
Insider Trading (Recent)
Last updated: Jun 27, 2026 9:35am (33m ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Cornog William L | P-Purchase | 10,000.00 | $16.38 | $163,800 |
| 2026-05-15 | Starr Ephraim | F-InKind | 3,621.00 | $16.02 | $58,008 |
| 2026-02-05 | Koffey Quentin | A-Award | 5,663.00 | $0.00 | $0 |
| 2026-04-28 | MARTIN WILLIAM E. III | A-Award | 17,790.00 | $24.24 | $431,230 |
| 2026-04-06 | MARTIN WILLIAM E. III | 0.00 | $0.00 | $0 | |
| 2026-02-05 | Cornog William L | 0.00 | $0.00 | $0 | |
| 2026-02-06 | Nova Tina Susan | A-Award | 5,663.00 | $27.85 | $157,715 |
| 2026-02-05 | Cornog William L | A-Award | 5,663.00 | $0.00 | $0 |
| 2026-02-05 | Madaus Martin D | A-Award | 5,663.00 | $0.00 | $0 |
| 2026-02-05 | Doshi Dipal | A-Award | 5,663.00 | $27.85 | $157,715 |
| 2026-02-05 | Casal Frank | A-Award | 7,243.00 | $27.85 | $201,718 |
| 2026-02-05 | McLaughlin Erica | A-Award | 5,663.00 | $27.85 | $157,715 |
| 2026-02-05 | Davis Robyn C | A-Award | 5,663.00 | $0.00 | $0 |
| 2025-11-24 | Marotta John | A-Award | 118,194.00 | $0.00 | $0 |
| 2025-11-24 | Marotta John | A-Award | 122,269.00 | $0.00 | $0 |
| 2025-11-24 | Lin Lawrence Y. | A-Award | 36,681.00 | $0.00 | $0 |
| 2025-11-24 | Pirogova Olga | A-Award | 16,303.00 | $0.00 | $0 |
| 2025-11-24 | Zhou Ginger | A-Award | 13,042.00 | $0.00 | $0 |
| 2025-11-24 | Starr Ephraim | A-Award | 34,235.00 | $0.00 | $0 |
| 2025-05-20 | Cornog William L | P-Purchase | 2,748.00 | $27.37 | $75,213 |
Dividend History (Last 20)
Last updated: Jun 23, 2026 6:40pm (3d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2021-12-02 | $0.10 | 2021-11-10 | 2021-12-03 | 2021-12-23 |
| 2021-09-02 | $0.10 | 2021-08-05 | 2021-09-03 | 2021-09-24 |
| 2021-06-03 | $0.10 | 2021-05-10 | 2021-06-04 | 2021-06-25 |
| 2021-03-04 | $0.10 | 2021-02-02 | 2021-03-05 | 2021-03-26 |
| 2020-12-03 | $0.10 | 2020-11-10 | 2020-12-04 | 2020-12-17 |
| 2020-09-03 | $0.10 | 2020-07-30 | 2020-09-04 | 2020-09-25 |
| 2020-06-04 | $0.10 | 2020-04-30 | 2020-06-05 | 2020-06-26 |
| 2020-03-05 | $0.10 | 2020-02-06 | 2020-03-06 | 2020-03-27 |
| 2019-12-05 | $0.10 | 2019-11-01 | 2019-12-06 | 2019-12-20 |
| 2019-09-05 | $0.10 | 2019-08-01 | 2019-09-06 | 2019-09-27 |
| 2019-06-06 | $0.10 | 2019-04-29 | 2019-06-07 | 2019-06-28 |
| 2019-02-28 | $0.10 | 2019-02-05 | 2019-03-01 | 2019-03-22 |
| 2018-12-06 | $0.10 | 2018-11-19 | 2018-12-07 | 2018-12-20 |
| 2018-09-06 | $0.10 | 2018-08-06 | 2018-09-07 | 2018-09-28 |
| 2018-05-31 | $0.10 | 2018-05-01 | 2018-06-01 | 2018-06-22 |
| 2018-03-01 | $0.10 | 2018-02-01 | 2018-03-02 | 2018-03-23 |
| 2017-11-30 | $0.10 | 2017-11-09 | 2017-12-01 | 2017-12-22 |
| 2017-09-07 | $0.10 | 2017-08-02 | 2017-09-08 | 2017-09-29 |
| 2017-05-31 | $0.10 | 2017-04-27 | 2017-06-02 | 2017-06-23 |
| 2017-03-01 | $0.10 | 2017-02-01 | 2017-03-03 | 2017-03-24 |
Narrative Economics
market-narrative step).